Science In Action - Covid- 19 – Good news on immunity

Tests on patients for up to 8 months following their infection with SARS- CoV-2 suggests an immune response can persist. Alessandro Sette and Daniela Weiskopf at the La Jolla Institute in California are optimistic this could mean vaccines would also confer long lasting immunity.

An analysis of samples from Kenya’s blood banks by Sophie Uyoga at the KEMRI-Wellcome Research Programme reveals far more people in Kenya contracted the virus than was previously know. The figures mean Kenya has similar levels of infection to many European countries.

And a study of mosquitoes by Louis Lambrechts of the Pasteur Institute in Paris reveals why Zika, a virus originating in Africa is much more prevalent in other parts of the world.

We also look at the future of the Nile. Ethiopia is building a massive Dam which will have consequences for Sudan and Egypt who are reliant on the Nile’s waters says hydrologist Hisham Eldardiry from the University of Washington, Seattle.

(Image: Credit: Getty Images)

Presenter: Roland Pease Producer: Julian Siddle

Short Wave - Happy (Harm Reduction) Thanksgiving!

The safest way to have Thanksgiving this year is to stay at home. But realistically, we know many people will still be traveling to gather with loved ones. So in this episode, Emily and Maddie outline ways to gather as safely as possible. We'll cover best practices for quarantining before the trip, testing, ventilation and food preparation. That way, this Thanksgiving you can pass the turkey, hold the 'rona.

Additional Resources:
CDC Holiday Guidelines
Aerosol & Ventilation FAQ
Short Wave Coronavirus Testing Episode

Email the show at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Short Wave - Trump Administration Lifts Protections For Largest National Forest In US

The Trump administration has officially eliminated federal protections for Alaska's Tongass National Forest, the largest intact temperate rainforest in the world. With the rollback of the Roadless Rule, nine million previously-protected acres are now open further to potential development. What does that mean for trees that have been storing carbon for centuries?

For more on this story, check out the episode page. You can email the show at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Short Wave - Who Gets The Vaccine First? And How Will They Get It?

Developing a safe and effective coronavirus vaccine will be crucial to getting the pandemic under control. Also important, distributing it throughout the country once it's been approved. NPR science reporter Pien Huang tells us which high risk groups will get it first, how the vaccine will be distributed (including some challenges), and who's footing the bill for all of this.

Email the show at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Unexpected Elements - Covid-19 defeats US Marines

The WHO is working with China to try and pinpoint the source of SARS- COV-2. Sian Griffiths, Emeritus Professor of Public Health at the Chinese University of Hong Kong says there are lessons we can learn from the investigation she led into the original SARS outbreak back in 2003. That inquiry revealed how SARS had spread from bats to humans via civet cats.

A Covid-19 vaccine claims to be 90% effective. It uses genetic material, messenger RNA. Daniel Anderson of Harvard MIT Health Science tells us about the huge potential of mRNA to provide treatments for many medical conditions.

However, rolling out such a vaccine globally faces a huge range of economic and practical obstacles as ethicist Nicole Hassoun of Binghamton University explains.

And a unique experiment shows despite a vast range of precautions including being isolated US Marines have contracted Covid -19. Stuart Sealfon, Professor of Neurology at Mount Sinai Hospitals says this study shows we need testing to be integrated more thoroughly into everyday life and that many of the precautions we currently use may not be enough to prevent transmission.

We all feel pain on a regular basis; when we stub a toe, break a bone or even experience heartbreak. Bebeto from Cameroon wants to know how to cope with a pain in his wrist that just won’t go away. Does a positive mindset help? Or perhaps meditation? Marnie Chesterton speaks to psychologists and neuroscientists to find the answers.

We hear from two people with very different experiences of pain. Lucy has fibromyalgia and experiences pain all over her body every day. While Stephen has a rare genetic condition which means he doesn’t feel physical pain at all. But they both argue that pain shouldn’t always be unwanted. Perhaps we need to embrace and accept our pain in order to beat it.

(Image: Credit: Getty Images)

Unexpected Elements - Covid-19 defeats US Marines

The WHO is working with China to try and pinpoint the source of SARS- COV-2. Sian Griffiths, Emeritus Professor of Public Health at the Chinese University of Hong Kong says there are lessons we can learn from the investigation she led into the original SARS outbreak back in 2003. That inquiry revealed how SARS had spread from bats to humans via civet cats.

A Covid-19 vaccine claims to be 90% effective. It uses genetic material, messenger RNA. Daniel Anderson of Harvard MIT Health Science tells us about the huge potential of mRNA to provide treatments for many medical conditions.

However, rolling out such a vaccine globally faces a huge range of economic and practical obstacles as ethicist Nicole Hassoun of Binghamton University explains.

And a unique experiment shows despite a vast range of precautions including being isolated US Marines have contracted Covid -19. Stuart Sealfon, Professor of Neurology at Mount Sinai Hospitals says this study shows we need testing to be integrated more thoroughly into everyday life and that many of the precautions we currently use may not be enough to prevent transmission.

We all feel pain on a regular basis; when we stub a toe, break a bone or even experience heartbreak. Bebeto from Cameroon wants to know how to cope with a pain in his wrist that just won’t go away. Does a positive mindset help? Or perhaps meditation? Marnie Chesterton speaks to psychologists and neuroscientists to find the answers.

We hear from two people with very different experiences of pain. Lucy has fibromyalgia and experiences pain all over her body every day. While Stephen has a rare genetic condition which means he doesn’t feel physical pain at all. But they both argue that pain shouldn’t always be unwanted. Perhaps we need to embrace and accept our pain in order to beat it.

(Image: Credit: Getty Images)

CrowdScience - How can I beat pain?

We all feel pain on a regular basis; when we stub a toe, break a bone or even experience heartbreak. Bebeto from Cameroon wants to know how to cope with a pain in his wrist that just won’t go away. Does a positive mindset help? Or perhaps meditation? Marnie Chesterton speaks to psychologists and neuroscientists to find the answers. We hear from two people with very different experiences of pain. Lucy has fibromyalgia and experiences pain all over her body every day. While Stephen has a rare genetic condition which means he doesn’t feel physical pain at all. But they both argue that pain shouldn’t always be unwanted. Perhaps we need to embrace and accept our pain in order to beat it. Presented by Marnie Chesterton. Produced by Caroline Steel for the BBC World Service

[Image: Man in pain. Credit: Getty Images]

Short Wave - The COVID-19 Vaccine Trial Results: What They Mean, What Comes Next

Interim results are in from a large trial of an experimental COVID-19 vaccine. Drug maker Pfizer, working with German company BioNTech, says its vaccine appears to be working really well — it was found to be more than 90 percent effective. Today on Short Wave, host Maddie Sofia talks to NPR science correspondent Joe Palca about what that efficacy number means, details of the study and what more information about the vaccine researchers are awaiting.

Reach the show by emailing us at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Science In Action - Covid-19 defeats US Marines

The WHO is working with China to try and pinpoint the source of SARS- COV-2. Sian Griffiths, Emeritus Professor of Public Health at the Chinese University of Hong Kong says there are lessons we can learn from the investigation she led into the original SARS outbreak back in 2003. That inquiry revealed how SARS had spread from bats to humans via civet cats.

A Covid-19 vaccine claims to be 90% effective. It uses genetic material, messenger RNA. Daniel Anderson of Harvard MIT Health Science tells us about the huge potential of mRNA to provide treatments for many medical conditions.

However, rolling out such a vaccine globally faces a huge range of economic and practical obstacles as ethicist Nicole Hassoun of Binghamton University explains.

And a unique experiment shows despite a vast range of precautions including being isolated US Marines have contracted Covid -19. Stuart Sealfon, Professor of Neurology at Mount Sinai Hospitals says this study shows we need testing to be integrated more thoroughly into everyday life and that many of the precautions we currently use may not be enough to prevent transmission.

(Image: Credit: Getty Images)

Presenter: Roland Pease Producer: Julian Siddle

Short Wave - A Call For Equity In Genomics Research

In the future, genomic research could lead to new treatments for human disease. It turns the data in our DNA into a global commodity. But historically, minoritized communities have been left out of this research. Keolu Fox is a genome scientist trying to change that and advocate for a more equitable approach when Indigenous and other underrepresented communities do participate.

Read Keolu's paper, "The Illusion of Inclusion", in the New England Journal of Medicine.

Reach the show by emailing us at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy